DIACOMIT® (stiripentol) is an FDA-approved antiseizure medication developed specifically for seizures associated with Dravet syndrome in children as young as 6 months (weighing 15 lb or more) and taking clobazam. It is clinically proven to reduce the frequency and duration of Dravet seizures.1
We know that finding the right combination of antiseizure treatments for your child is critical. With DIACOMIT (stiripentol), seizure relief is possible, starting as early as 6 months.
DIACOMIT is proven to significantly reduce generalized clonic or tonic clonic seizures. 1,6-8Review the Research
DIACOMIT is available in different forms and doses to fit your child’s unique needs.Get Started
Biocodex is By Your Side, making it easier than ever to fill a prescription for DIACOMIT.Find Support